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  Anti-inflammatory effects of Houttuynia cordata supercritical 
extract  (HSE)  were  investigated  in  a  carrageenan-air 
pouch model. HSE (200 mg/kg, oral) suppressed exudation 
and albumin leakage, as well as inflammatory cell infiltration. 
Dexamethasone (2 mg/kg, i.p.) only decreased exudation 
and  cell  infiltration,  while  indomethacin  (2  mg/kg,  i.p.) 
reduced  exudate  volume  and  albumin  content.  HSE 
lowered  tumor-necrosis  factor  (TNF)-α  and  nitric  oxide 
(NO), as well as prostaglandin E2 (PGE2). Dexamethasone 
only reduced TNF-α and NO, while indomethacin decreased 
TNF-α and PGE2. The suppressive activity of HSE on NO 
and PGE2 production was confirmed in RAW 264.7. These 
results  demonstrate  that  HSE  exerts  anti-inflammatory 
effects by inhibiting both TNF-α-NO and cyclooxygenase 
II-PGE2 pathways.
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Traditionally, Houttuynia (H.) cordata Thunb has been 
used as an Oriental medicine for the treatment of inflam-
matory diseases such as ulcerative colitis [3]. Previous 
studies showed that H. cordata extracts had antiviral and 
antibacterial [2,6], antiallergic [5], antioxidant and antimutagenic 
activities [1].
The major constituents of H. cordata essential oil 
included methyl nonyl ketone, β-myrcene,  β-pinene, 
α-pinene,  α-terpineol and n-decanoic acid. The anti- 
inflammatory effects of the oil were also demonstrated [7]. 
In the present study, we investigated the anti-inflammatory 
activity of H. cordata supercritical extract (HSE) in both 
macrophages and a carrageenan-induced air pouch inflam-
mation model [9,10]. 
The aerial part of H. cordata (10 kg) was extracted for 2 
h under CO2 supercritical conditions and the extract was 
collected as previously described [4]. The extract (yield = 
150 g) was dissolved in soybean oil, and orally administered 
at 4 mL/kg.
For the effects of HSE on the secretion of inflammatory 
mediators, murine macrophages, RAW 264.7 cells (ATCC, 
USA; 1 × 10
6 cells/mL), were incubated with HSE (final 
0.001∼1%) and lipopolysaccharide (LPS, final 2.5 μg/mL) 
for 24 h. Levels of nitric oxide (NO) and prostaglandin E2 
(PGE2) were measured by Griess reagent (Sigma, USA) 
and enzyme immunoassay (EIA) using a Correlate-EIA kit 
(Assay Designs, USA), respectively.
Male ICR mice (body weight 28∼32 g; n = 8/group) were 
subcutaneously injected with 10 mL of sterile air into the 
back side to form a pouch [9,10]. After 2 and 5 days, the 
pouch was reinjected with 5 mL of air. Twenty four h after 
the final air injection, HSE (65 or 200 mg/kg) was orally 
administered, followed 1 h later by injection with 1 mL of 
lambda carrageenan (1% in saline; Sigma, USA) into the 
pouch. Dexamethasone (2 mg/kg; Sigma, USA) or 
indomethacin (2 mg/kg; Sigma, USA) were used as a 
positive control. The animal experiments were approved 
by the Institutional Animal Care and Use Committee of the 
Laboratory Animal Research Center, Chungbuk National 
University, Korea.
The pouch was washed with 1 mL of cold saline after 6 h, 
and the net volume of lavage fluid was recorded. Total 
numbers of inflammatory cells and albumin, a marker of 
vascular leakage, were determined using a coulter counter 
and a blood biochemistry analyzer, respectively. Tumor- 
necrosis factor (TNF)-α and interleukin (IL)-6 were 
analyzed using ELISA kits (Komabiotech, Korea). Tests of 
significance were performed using Duncan’s multiple-range 
test after one-way ANOVA with p ＜ 0.05 as a criterion of 274    Sunhee Shin et al.
Table 1. Effects of Houttuynia cordata supercritical extract (HSE) on the nitric oxide (NO) and prostaglandin E2 (PGE2) production 
from RAW 264.7 cells stimulated with lipopolysaccharide (LPS)
Treatment
NO PGE2
Conc. (μM) Inhibition (%) Conc. (μg/mL) Inhibition (%)
  Vehicle   1.20 ± 0.13 - 0.16 ± 0.03 -
  LPS alone (2.5 μg/mL) 42.10 ± 7.21* -   3.98 ± 0.48* -
  +HSE (0.001%) 14.80 ± 2.13
† 66.7 3.74 ± 0.50   6.3
  +HSE (0.01%)   14.5 ± 1.78
† 67.5  3.01 ± 0.42
† 25.4
  +HSE (0.1%)   5.30 ± 0.90
† 90.0  2.42 ± 0.45
† 40.8
  +HSE (1%)   2.00 ± 0.31
† 98.0  0.91 ± 0.14
† 80.4
*Significantly different from vehicle control (p ＜ 0.05). 
†Significantly different from LPS alone (p ＜ 0.05). Conc.: concentration.
Table 2. Effects of dexamethasone, indomethacin and HSE on carrageenan-induced exudation and inflammatory cell infiltration in
mouse air pouches (n = 8)
Treatment









WBCs Neutrophils Monocytes Lymphocytes
Vehicle 0.65 ± 0.12 - 0.81 ± 0.12 - 0.86 ± 0.21 0.17 ± 0.06 0.07 ± 0.02 0.55 ± 0.15
Carrageenan alone 1.17 ± 0.12* - 2.14 ± 0.22* - 8.80 ± 1.32* 1.01 ± 0.19* 0.46 ± 0.17* 7.07 ± 1.58*
+Dexamethasone 0.82 ± 0.08
† 67.1 1.54 ± 0.43
† 45.1 4.54 ± 1.19
† 0.80 ± 0.23 0.20 ± 0.05
† 2.51 ± 0.75
†
+Indomethacin 0.86 ± 0.08
† 60.0 1.51 ± 0.12
† 47.4 8.54 ± 1.46 1.09 ± 0.29 0.38 ± 0.10 6.76 ± 2.08
+HSE (65 mg/kg) 1.07 ± 0.10 19.2 1.81 ± 0.43 24.8 8.13 ± 1.92 1.67 ± 0.28 0.74 ± 0.16 4.21 ± 1.39
†
+HSE (200 mg/kg) 0.93 ± 0.04
† 46.7 1.32 ± 0.21
† 61.7 4.94 ± 1.44
† 0.62 ± 0.21
† 0.43 ± 0.17 3.85 ± 0.85
†
*Significantly different from vehicle (p ＜ 0.05). 
†Significantly different from carrageenan alone (p < 0.05).
difference.
LPS treatment increased the secretion of both NO and 
PGE2 from macrophages, up to 25∼30 fold of control 
levels, which were substantially suppressed by HSE in a 
concentration-dependent manner (Table 1).
Injection of carrageenan into mouse air pouches 
significantly increased the exudate volume and the 
albumin concentrations in the exudates (Table 2). Oral 
treatment with HSE suppressed the carrageenan- induced 
increases in the exudate volume and albumin leakage at 
200 mg/kg (46.7% and 61.7%, respectively). Intraperitoneal 
administration of dexamethasone and indomethacin also 
reduced both the exudate volumes (67.1% and 60.0% 
respectively) and albumin contents (45.1% and 47.4% 
respectively). Total white blood cells (WBC) in the exudates 
were greatly increased by carrageenan. Interestingly, infil-
trating inflammatory cells were suppressed to half level by 
HSE (200 mg/kg) and dexamethasone, but not by indo-
methacin.
Carrageenan enormously enhanced major inflammatory 
cytokines TNF-α and IL-6 in the exudates (Table 3). 
Administration of HSE, dexamethasone and indomethacin 
significantly lowered the carrageenan-induced increases 
of TNF-α. In contrast, the increased IL-6 level was not 
significantly attenuated by any of the compounds. Interestingly, 
HSE nearly completely blocked the carrageenan-induced 
increases in both NO and PGE2.
HSE attenuated not only the secretion of both major 
inflammatory mediators, NO and PGE2  but also 
carrageenan-induced inflammatory responses in animals. 
The numbers of neutrophils and lymphocytes increased by 
carrageenan were reduced following treatment with HSE. 
This was an effect obtained by dexamethasone, but not by 
indomethacin (1∼2 mg/kg) [8,10]. The corticosteroid-like 
effect of HSE was confirmed by its inhibitory action on 
TNF-α and NO. Therefore, the effect of HSE might be due 
to the suppression of signaling activity, as supported by the 
highly-sensitive suppression by HSE of NO secretion from 
macrophages.
HSE exhibited an additional inhibitory activity on the in 
vitro and in vivo release of PGE2, suggesting that HSE 
directly inhibits COX II or deactivates inflammatory cells Anti-inflammatory effects of Houttuynia cordata supercritical extract    275
Table 3. Effects of dexamethasone, indomethacin and HSE on the carrageenan-induced increases in cytokines and inflammatory 
mediators in mouse air pouch exudates (n = 8)
Treatment
















Vehicle     5.0 ± 0.1 -     2.0 ± 0.4 - 0.391 ± 0.074 - 1,228.1 ± 43.8 -
Carrageenan alone 181.7 ± 50.0* - ＞ 500.0* - 0.774 ± 0.112* - 1,439.5 ± 18.4* -
+Dexamethasone   14.1 ± 5.8
† 94.9   442.8 ± 53.0 11.5 0.054 ± 0.023
† 188.0 1,411.3 ± 23.7   13.3
+Indomethacin 108.2 ± 22.4
† 41.6   473.8 ± 20.5   5.3 0.663 ± 0.203   29.0 1,222.3 ± 11.0
† 102.7
+HSE (65 mg/kg)   56.7 ± 15.2
† 70.7 ＞ 500.0   0.0 0.412 ± 0.125
†   94.5 1,149.6 ± 51.6
† 137.1
+HSE (200 mg/kg)   79.1 ± 20.1
† 58.1 ＞ 500.0   0.0 0.403 ± 0.187
†   96.9 1,218.5 ± 41.2
† 104.5
TNF-α: tumor-necrosis factor-α, IL-6: interleukin-6. *Significantly different from vehicle control (p ＜ 0.05). 
†Significantly different from 
carrageenan alone (p ＜ 0.05).
expressing COX II. In spite of a less-sensitive inhibition 
compared to NO from macrophages, in vivo production of 
PGE2 was fully suppressed by HSE treatment. Such a 
difference between in vitro and in vivo studies may be due 
to the different stimulators, LPS and carrageenan, respectively.
Notably, our result show that HSE (IC50 < 0.001%) was 
much superior to an aqueous extract (IC50 ≒ 0.1%) in the 
inhibition of NO production by macrophages [10].
In summary, we first demonstrated the anti-inflammatory 
effects of HSE by analyzing mediators in the two major 
pathways of inflammation (TNF-α-NO and COX II-PGE2). 
Mechanistically, it was believed that HSE played a dual actions 
in the inflammatory process, dexamethasone- and indomethacin- 
like effects, implying that additional constituents inhibiting 
the COX II-PGE2 pathway might be present in HSE, in 
addition to those acting on the TNF-α-NO pathway. 
Therefore, HSE could be a better drug candidate or adjunct 
than aqueous extracts for the relief of various types of 
inflammation that are responsive to corticosteroids or 
NSAID.
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